2021 update of the International Council for Standardization in Haematology recommendations for laboratory measurement of direct oral anticoagulants

J Douxfils, DM Adcock, SM Bates… - Thrombosis and …, 2021 - thieme-connect.com
In 2018, the International Council for Standardization in Haematology (ICSH) published a
consensus document providing guidance for laboratories on measuring direct oral …

The International Society for Heart and Lung Transplantation (ISHLT) guidelines for the care of heart transplant recipients

A Velleca, MA Shullo, K Dhital, E Azeka… - The Journal of Heart …, 2023 - jhltonline.org
Cochrane, Maria Crespo Leiro, Anne Dipchand, Brian Feingold, Kathleen Grady, Edward
Horn, Maryl Johnson, Donna Mancini, Sean Pinney, Heather Ross, Kari Wujcik, Andreas …

International Council for Standardization in Haematology (ICSH) recommendations for laboratory measurement of direct oral anticoagulants

RC Gosselin, DM Adcock, SM Bates… - Thrombosis and …, 2018 - thieme-connect.com
This guidance document was prepared on behalf of the International Council for
Standardization in Haematology (ICSH) for providing haemostasis-related guidance …

Efficacy and safety of non-vitamin K antagonist oral anticoagulants in pediatric venous thromboembolism treatment and thromboprophylaxis: a systematic review of the …

JW Branstetter, AL Kiskaddon, MA King… - … in Thrombosis and …, 2021 - thieme-connect.com
Venous thromboembolism (VTE) in children can lead to significant morbidity and mortality.
Traditionally, treatment for thrombotic events in pediatric patients has been limited mainly to …

Computational modeling of blood component transport related to coronary artery thrombosis in Kawasaki disease

N Grande Gutiérrez, M Alber, AM Kahn… - PLoS computational …, 2021 - journals.plos.org
Coronary artery thrombosis is the major risk associated with Kawasaki disease (KD). Long-
term management of KD patients with persistent aneurysms requires a thrombotic risk …

Apixaban for prevention of thromboembolism in pediatric heart disease

RM Payne, KM Burns, AC Glatz, C Male, A Donti… - Journal of the American …, 2023 - jacc.org
Background Children with heart disease frequently require anticoagulation for
thromboprophylaxis. Current standard of care (SOC), vitamin K antagonists or low-molecular …

[HTML][HTML] Real-world use of apixaban for the treatment and prevention of thrombosis in children with cardiac disease

C VanderPluym, P Esteso, A Ankola, A Hellinger… - Journal of Thrombosis …, 2023 - Elsevier
Background Direct oral anticoagulants use in pediatric cardiology is poorly defined.
Objective We present the largest experience of apixaban use in children with heart disease …

50 years of pediatric hemostasis: knowledge, diagnosis, and treatment

S Levy-Mendelovich, O Cohen… - … in Thrombosis and …, 2023 - thieme-connect.com
Studies from the past 50 years have contributed to the expanding knowledge regarding
developmental hemostasis. This is a dynamic process that begins in the fetal phase and is …

Direct oral anticoagulants for use in paediatrics

J Jaffray, G Young - The Lancet Child & Adolescent Health, 2022 - thelancet.com
With the increasing incidence of thromboembolism in children and improvement in
management for patients with medically complex diseases, expanded availability of safe …

Evaluation, analysis, and reporting of medication adherence for clinical trials of anticoagulants in children: guidance from the ISTH SSC Subcommittee on Pediatric …

ME McGrady, V Ignjatovic, S Jones, A Bruce… - Journal of Thrombosis …, 2024 - Elsevier
In response to growing recognition that nonadherence prevents children, adolescents, and
young adults from achieving the therapeutic benefits of anticoagulant medication, the …